Why Does Retinitis Pigmentosa Spare Central Vision?
At a Glance
Retinitis pigmentosa initially attacks rod cells, which control your peripheral and night vision. This causes tunnel vision. Cone cells, which control central reading vision, survive much longer. This is why you can maintain 20/20 central vision but still be considered legally blind.
In this answer
3 sections
You are able to read the tiny letters on an eye chart because retinitis pigmentosa (RP) initially attacks the specific cells responsible for your side (peripheral) vision, while temporarily sparing the cells responsible for your straight-ahead (central) vision. This creates a confusing reality where you can have perfect 20/20 reading vision but still be considered legally blind. Legal blindness is not based solely on how sharply you see the center of an image; it also factors in how much of the surrounding world you can see.
The Anatomy of Your Retina: Rods vs. Cones
The back of your eye is lined with light-sensitive tissue called the retina. This tissue relies on two main types of specialized light-sensing cells (photoreceptors) to capture images [1]:
- Rods: These cells are heavily concentrated in the outer edges (periphery) of your retina. Rods are responsible for your side vision and your ability to see in dim light or darkness [1].
- Cones: These cells are tightly packed in the very center of your retina (an area called the macula, and specifically the fovea). Cones handle sharp, detailed central vision—like reading—and allow you to see colors [1][2].
Retinitis pigmentosa is a genetic condition that typically acts as a rod-cone dystrophy [3]. This means the genetic mutations primarily target the rod cells first [4]. As these rods break down and die, your ability to see in the dark (night blindness) and your side vision slowly disappear. Many patients describe this feeling as if they are looking through a narrow straw or a small keyhole.
Why Central Vision Survives Longer
Because the cone cells are not the primary target of most RP mutations, they survive much longer than the rods [5]. This is why you can retain 20/20 central visual acuity for many years—the dense cluster of cones in the center of your eye is still healthy and functioning.
However, cones and rods share a delicate ecosystem. As large numbers of rod cells die, they stop producing vital support factors and cause metabolic stress and inflammation in the retina [4][5]. Over time—a process that typically takes decades—this secondary stress eventually impacts the surviving cone cells, which is why central vision can ultimately be affected in the later stages of the disease [5].
If you notice a sudden blurring of your central vision, it is not always due to cone death. A common complication in RP is Cystoid Macular Edema (CME), where fluid accumulates in the central retina [6]. CME affects approximately 32% of patients at diagnosis, and unlike permanent cone degeneration, it is often treatable with medications [6].
Protecting Your Remaining Vision
While the progression of RP is largely genetic, you can take practical steps to reduce metabolic stress on your remaining cone cells. Wearing wrap-around sunglasses outdoors to block UV light can help limit oxidative damage. Additionally, some doctors discuss nutritional supplements like Vitamin A or lutein, though evidence on their effectiveness in slowing RP is limited and mixed [7]. Always consult your care team before starting any new supplements.
20/20 Vision and Legal Blindness
It can be incredibly frustrating to explain to others—and even to understand yourself—how you can be legally blind while still being able to read small print.
In many countries, including the United States, “legal blindness” is defined by meeting either of two distinct criteria [8]:
- Visual Acuity: Having 20/200 vision or worse in your better eye, even with glasses or contacts.
- Visual Field: Having a visual field (the total area you can see without moving your eyes) that has shrunk to 20 degrees or less in your better eye. Your eye doctor measures this using a specific test called perimetry (or a visual field test).
In retinitis pigmentosa, the continuous loss of peripheral vision causes the visual field to constrict into “tunnel vision” [8]. A person’s visual field area often deteriorates faster than their visual acuity [9]. A constricted visual field is a major cause of legal blindness for people with RP [8][9]. Even if you have perfect 20/20 central visual acuity, a severely restricted visual field (20 degrees or less) makes it dangerous to drive and difficult to navigate without mobility aids, fully qualifying as legal blindness.
Common questions in this guide
Why can I have 20/20 vision but still be legally blind with RP?
What is the difference between rod and cone cells in retinitis pigmentosa?
Will retinitis pigmentosa eventually cause central vision loss?
Why did my central vision suddenly become blurry?
How can I protect my remaining central vision with retinitis pigmentosa?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the exact measurement of my visual field in degrees, and how often will we test this using perimetry?
- 2.Does my latest optical coherence tomography (OCT) scan show any signs of Cystoid Macular Edema (CME) in my central vision?
- 3.What specific UV protection or sunglass tint (e.g., amber or plum) do you recommend to help reduce oxidative stress on my remaining cone cells?
- 4.Given my specific genetic mutation, should we discuss any nutritional supplements, or are there any I should specifically avoid?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (9)
- 1
Deletion of Emc1 in photoreceptor cells causes retinal degeneration in mice.
Li X, Jiang Z, Su Y, et al.
The FEBS journal 2023; (290(17)):4356-4370 doi:10.1111/febs.16807.
PMID: 37098815 - 2
Molecular tuning of calcium dependent processes by neuronal calcium sensor proteins in the retina.
Koch KW
Biochimica et biophysica acta. Molecular cell research 2023; (1870(6)):119491 doi:10.1016/j.bbamcr.2023.119491.
PMID: 37230154 - 3
Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration.
Zhao L, Zabel MK, Wang X, et al.
EMBO molecular medicine 2015; (7(9)):1179-97 doi:10.15252/emmm.201505298.
PMID: 26139610 - 4
Inhibition of JNK ameliorates rod photoreceptor degeneration in a mouse model of retinitis pigmentosa.
Liao C, Chen S, Chen X, et al.
FEBS letters 2024; (598(21)):2683-2701 doi:10.1002/1873-3468.14978.
PMID: 39010325 - 5
Suppressing Retinal Remodeling to Mitigate Vision Loss in Photoreceptor Degenerative Disorders.
Kramer RH
Annual review of vision science 2023; (9()):131-153 doi:10.1146/annurev-vision-112122-020957.
PMID: 37713276 - 6
Optical coherence tomography analysis at initial diagnosis in patients with retinitis pigmentosa and associated cystoid macular edema.
Jung SH, Yi SU, Hwang BE, et al.
PloS one 2025; (20(6)):e0325654 doi:10.1371/journal.pone.0325654.
PMID: 40560841 - 7
Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review.
Brito-García N, Del Pino-Sedeño T, Trujillo-Martín MM, et al.
Eye (London, England) 2017; (31(2)):273-285 doi:10.1038/eye.2016.286.
PMID: 27935602 - 8
Disease progression of retinitis pigmentosa caused by PRPF31 variants in a Nordic population: a retrospective study with up to 36 years follow-up.
Lisbjerg K, Bertelsen M, Lyng Forman J, et al.
Ophthalmic genetics 2023; (44(2)):139-146 doi:10.1080/13816810.2022.2123006.
PMID: 36164253 - 9
Visual Field Progression in Retinitis Pigmentosa.
Xu M, Zhai Y, MacDonald IM
Investigative ophthalmology & visual science 2020; (61(6)):56 doi:10.1167/iovs.61.6.56.
PMID: 32589198
This page provides educational information about vision changes associated with retinitis pigmentosa. It does not replace professional medical advice from your ophthalmologist or retina specialist.
Get notified when new evidence is published on Retinitis pigmentosa.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.